Bionano Genomics has priced a public offering of 5 million shares at $2.00 each, raising approximately $10 million before expenses, with warrants potentially bringing an additional $20 million if exercised. The company intends to allocate these funds toward working capital and general corporate purposes to support ongoing development and operations in genomic analysis technologies.